Sherlock Biosciences and binx health said they plan to develop the world’s first rapid, point-of-care diagnostic test for COVID-19 using CRISPR technology.
The research showed that alternative TLN2 and ZNF521 genotypes explained significant inter-patient variation in relative abundance of two key pathogens. Wound diversity was lowest in Pseudomonas aeruginosa infected wounds, which had a significant negative linear relationship with healing rate.
The researchers from Chongqing Medical University in Chongqing, China, also found that people’s antibody response to SARS-CoV-2 may diminish rapidly after infection, which may have implications for the interpretation of negative serological results.
Sponsor: Bionano Genomics
Hailed for its gene editing power, Sherlock Bioscience’s COVID-19 diagnostic is the first CRISPR technology to gain FDA approval.Hailed for its gene editing power, Sherlock Bioscience’s COVID-19 diagnostic is the first CRISPR technology to gain FDA approval.
The coronavirus pandemic compels diagnostics companies to bring new assays, technologies to market.
This year’s list of innovative companies have all found, or developed, technology solutions that have allowed them to become innovators in their niche.
Foundation Medicine Eyes Liquid Biopsy Expansion, DNA Methylation Adoption, with Lexent Bio Acquisition
The acquisition expands Foundation Medicine’s liquid biopsy platforms by adding Lexent Bio's development-stage monitoring platform, which is based on low-pass whole-genome sequencing (WGS) and DNA methylation analysis.
Seven Bridges will apply to AlloSure the Seven Bridges Bioinformatics Ecosystem, a solution created to enable scientists to simplify complex analysis and reduce time to result by working in a common environment and automating concurrent processing of workflows efficiently and collaboratively.
It appears no one virus lineage was predominant in northern California, suggesting that transmission between communities was limited. Instead, virus introductions to the state were likely from people traveling from outside the studied counties and the state.